We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.06B
1-Year Est. Return 106.87%
This Fund
S&P 500
This Quarter Est. Return
+16.15%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$1.84B
AUM Growth
+$151M
Cap. Flow
-$272K
Cap. Flow %
-0.01%
Top 10 Hldgs %
17.12%
Holding
286
New
69
Increased
59
Reduced
53
Closed
49

Sector Composition

Rank Sector Weight
1 Healthcare 29.41%
2 Industrials 18.32%
3 Technology 17.88%
4 Consumer Discretionary 10.89%
5 Financials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMCI icon
1
Super Micro Computer
SMCI
$17.9B
$42M 2.28%
1,685,140
-1,571,470
-48% -$26.3M
CHDN icon
2
Churchill Downs
CHDN
$5.91B
$36.6M 1.98%
262,634
-10,412
-4% -$1.42M
CRS icon
3
Carpenter Technology
CRS
$25.6B
$31.7M 1.72%
564,965
ACAD icon
4
Acadia Pharmaceuticals
ACAD
$4.35B
$30.9M 1.68%
1,291,094
+83,792
+7% +$1.86M
GTLS
5
DELISTED
Chart Industries
GTLS
$30.9M 1.68%
193,405
+41,004
+27% +$5.24M
SMPL icon
6
Simply Good Foods
SMPL
$905M
$30.8M 1.67%
840,557
+601
+0.1% +$22.1K
TMDX icon
7
Transmedics
TMDX
$2.61B
$29.8M 1.61%
354,462
+1,089
+0.3% +$83.4K
TMCI icon
8
Treace Medical Concepts
TMCI
$271M
$28.7M 1.55%
1,120,875
FRPT icon
9
Freshpet
FRPT
$2.98B
$27.3M 1.48%
414,901
-3,854
-0.9% -$252K
FOUR icon
10
Shift4
FOUR
$4.15B
$27.1M 1.47%
399,394
-41,875
-9% -$2.75M
BPMC
11
DELISTED
Blueprint Medicines
BPMC
$26.1M 1.42%
413,327
+54,507
+15% +$2.96M
RETA
12
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$26M 1.41%
255,387
+369
+0.1% +$34.9K
MMSI icon
13
Merit Medical Systems
MMSI
$4.99B
$25.7M 1.39%
306,996
-101
-0% -$8.22K
TENB icon
14
Tenable Holdings
TENB
$3.57B
$25.5M 1.38%
584,628
+63,058
+12% +$2.58M
NVEE
15
DELISTED
NV5 Global
NVEE
$25M 1.35%
902,132
+57,036
+7% +$1.4M
MODN
16
DELISTED
MODEL N, INC.
MODN
$23.7M 1.29%
671,014
+30,107
+5% +$968K
NOG icon
17
Northern Oil and Gas
NOG
$2.28B
$23.4M 1.27%
682,449
+21,365
+3% +$692K
ISEE
18
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$23M 1.25%
584,464
-14,717
-2% -$519K
TNET icon
19
TriNet
TNET
$3B
$22.8M 1.24%
240,411
+11,221
+5% +$1.02M
LIVN icon
20
LivaNova
LIVN
$4.39B
$22.4M 1.22%
435,696
+211,594
+94% +$9.93M
PLNT icon
21
Planet Fitness
PLNT
$4.38B
$22.4M 1.21%
332,156
NEO icon
22
NeoGenomics
NEO
$2B
$22.1M 1.2%
1,374,783
PLMR icon
23
Palomar
PLMR
$3.61B
$21.8M 1.18%
374,988
+28,366
+8% +$1.52M
EXPO icon
24
Exponent
EXPO
$3.25B
$21.7M 1.18%
232,393
KTOS icon
25
Kratos Defense & Security Solutions
KTOS
$8.52B
$21.3M 1.15%
1,484,145
-777
-0.1% -$10.5K

Similar funds

Emerald Mutual Fund Advisers Trust's Q2 2023 Portfolio in Review

As of Q2 2023, Emerald Mutual Fund Advisers Trust held 286 positions worth $1.84B, up 8.9% from $1.69B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q2 2023 filing shows 69 new, 59 increased, 53 reduced and 49 closed positions. Its largest new stake was FTAI Aviation: 671,648 shares worth $21.3M. The largest sale was Super Micro Computer, an estimated $26.3M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.

  • Emerald Mutual Fund Advisers Trust's largest Q2 2023 buy was FTAI Aviation: 671,648 shares worth $21.3M.
  • Emerald Mutual Fund Advisers Trust added most to MannKind Corp in Q2 2023, an estimated $12M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q2 2023 reduction was Super Micro Computer, cutting an estimated $26.3M.
  • Emerald Mutual Fund Advisers Trust fully exited Alkermes in Q2 2023, selling an estimated $16M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 17% of its $1.84B portfolio in Q2 2023.
  • Emerald Mutual Fund Advisers Trust opened 69 new positions and closed 49 in Q2 2023.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 8.9% quarter-over-quarter to $1.84B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2023, filed 10 Aug 2023.